Vutrisiran for treating hereditary transthyretin-related amyloidosis

Register of interests (PDF 259 KB)

Equality Impact Assessment (Guidance development) (PDF 150 KB)

Final draft guidance

Final appraisal document Final Draft Guidance (PDF 128 KB)

Committee papers (PDF 3.77 MB)

Final scope (PDF 156 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 287 KB)

Equality Impact Assessment (Guidance development) (PDF 127 KB)

Final stakeholder list (PDF 168 KB)

Draft matrix post referral (PDF 171 KB)

Draft scope post referral (PDF 172 KB)